Jardiance

Jardiance Use In Pregnancy & Lactation

empagliflozin

Manufacturer:

Boehringer Ingelheim

Distributor:

Metro Drug
Full Prescribing Info
Use In Pregnancy & Lactation
Pregnancy: There are limited data from the use of Empagliflozin (Jardiance) in pregnant women. Nonclinical studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. As a precautionary measure it is recommended to avoid the use of Empagliflozin (Jardiance) during pregnancy unless clearly needed.
Lactation: No data in humans are available on excretion of empagliflozin into milk. Available nonclinical data in animals have shown excretion of empagliflozin in milk. A risk to human newborns/infants cannot be excluded. It is recommended to discontinue breast feeding during treatment with Empagliflozin (Jardiance).
Fertility: No studies on the effect on human fertility have been conducted for Empagliflozin (Jardiance). Nonclinical studies in animals do not indicate direct or indirect harmful effects with respect to fertility.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in